Literature DB >> 17055724

Chemically programmed antibodies: endothelin receptor targeting CovX-Bodies.

Venkata R Doppalapudi1, Nancy Tryder, Lingna Li, Teresa Aja, David Griffith, Francesca-Fang Liao, Giovanni Roxas, Mysore P Ramprasad, Curt Bradshaw, Carlos F Barbas.   

Abstract

Aryl sulfonamide-based endothelin antagonists were synthesized and covalently linked to the reactive lysine of the m38C2 antibody to create a series of CovX-Bodies. These chemically programmed antibodies behaved as potent endothelin receptor antagonists in vitro and had antitumor efficacy in a prostate cancer xenograft model which, on a molar basis, far exceeded the activity of the parent small molecule.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17055724     DOI: 10.1016/j.bmcl.2006.10.009

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  25 in total

1.  Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human.

Authors:  Dhaval K Shah; Alison M Betts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-12-06       Impact factor: 2.745

2.  Expanding the concept of chemically programmable antibodies to RNA aptamers: chemically programmed biotherapeutics.

Authors:  Ulrich Wuellner; Julia I Gavrilyuk; Carlos F Barbas
Journal:  Angew Chem Int Ed Engl       Date:  2010-08-09       Impact factor: 15.336

3.  Multiple catalytic aldolase antibodies suitable for chemical programming.

Authors:  Rajib Kumar Goswami; Zheng-Zheng Huang; Jane S Forsyth; Brunhilde Felding-Habermann; Subhash C Sinha
Journal:  Bioorg Med Chem Lett       Date:  2009-04-18       Impact factor: 2.823

4.  Targeted instant immunity.

Authors:  Claude F Meares
Journal:  Nat Biotechnol       Date:  2009-05       Impact factor: 54.908

5.  Instant immunity through chemically programmable vaccination and covalent self-assembly.

Authors:  Mikhail Popkov; Beatriz Gonzalez; Subhash C Sinha; Carlos F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

Review 6.  Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides.

Authors:  Lei Diao; Bernd Meibohm
Journal:  Clin Pharmacokinet       Date:  2013-10       Impact factor: 6.447

Review 7.  Chemically programmed antibodies.

Authors:  Christoph Rader
Journal:  Trends Biotechnol       Date:  2014-03-11       Impact factor: 19.536

8.  Antibody conjugation approach enhances breadth and potency of neutralization of anti-HIV-1 antibodies and CD4-IgG.

Authors:  Julia Gavrilyuk; Hitoshi Ban; Hisatoshi Uehara; Shannon J Sirk; Karen Saye-Francisco; Angelica Cuevas; Elise Zablowsky; Avinash Oza; Michael S Seaman; Dennis R Burton; Carlos F Barbas
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

9.  Beta-lactam-based approach for the chemical programming of aldolase antibody 38C2.

Authors:  Julia I Gavrilyuk; Ulrich Wuellner; Carlos F Barbas
Journal:  Bioorg Med Chem Lett       Date:  2009-01-15       Impact factor: 2.823

10.  Application of a trifunctional reactive linker for the construction of antibody-drug hybrid conjugates.

Authors:  Joshua D Thomas; Thomas Hofer; Christoph Rader; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2008-10-14       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.